JPS638960B2 - - Google Patents
Info
- Publication number
- JPS638960B2 JPS638960B2 JP5800679A JP5800679A JPS638960B2 JP S638960 B2 JPS638960 B2 JP S638960B2 JP 5800679 A JP5800679 A JP 5800679A JP 5800679 A JP5800679 A JP 5800679A JP S638960 B2 JPS638960 B2 JP S638960B2
- Authority
- JP
- Japan
- Prior art keywords
- εcamp
- carbamoyl
- formula
- cyano
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 10
- 239000003513 alkali Substances 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 5
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- -1 alkali metal salts Chemical class 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000005521 carbonamide group Chemical group 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 229940023913 cation exchange resins Drugs 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007333 cyanation reaction Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Description
【発明の詳細な説明】
本発明は、一般式
(式中Rはシアノ基、カルバモイル基又はカルボ
キシル基を意味する)で表わされる新規な2−置
換−1,N6−エテノ−アデノシン−3′,5′−環状
リン酸(以下1,N6−エテノ−アデノシン−3′,
5′−環状リン酸をεCAMPと略称する)に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to the general formula A novel 2-substituted-1,N 6 -etheno-adenosine-3',5'-cyclic phosphoric acid (hereinafter referred to as 1,N 6 -etheno-adenosine-3′,
5′-cyclic phosphoric acid is abbreviated as εCAMP).
式の化合物は、抗アレルギー作用、中枢神経
興奮作用、血小板凝集作用、利尿作用、循環器系
に対する作用(例えば血圧降下作用、心筋抑制作
用等)、さらに制癌作用等の優れた薬理作用を有
し医薬として有用であり、また生化学試薬例えば
ホスホジエステラーゼ活性測定用試薬として用い
られる。 The compound of the formula has excellent pharmacological effects such as antiallergic action, central nervous system stimulant action, platelet aggregation action, diuretic action, action on the circulatory system (e.g. hypotensive action, myocardial depressant action, etc.), and anticancer action. It is useful as a medicine, and is also used as a biochemical reagent, such as a reagent for measuring phosphodiesterase activity.
Rがシアノ基である式の化合物(2−シアノ
−εCAMP)は、次式
(式中Xはハロゲン原子を意味する)で表わされ
る2−ハロゲノ−εCAMPにシアン化アルカリを
作用させることにより製造できる。 The compound of the formula (2-cyano-εCAMP) in which R is a cyano group is represented by the following formula It can be produced by reacting 2-halogeno-εCAMP represented by the formula (wherein X means a halogen atom) with an alkali cyanide.
式の化合物は、例えば2−メルカプト−
εCAMPをハロゲン化することにより得られ(特
開昭53−12891号明細書参照)、例えば2−ヨード
−εCAMP、2−クロロ−εCAMP又は好ましく
は2−ブロモ−εCAMPが用いられる。これら式
の化合物は、環状リン酸部における遊離酸の形
でならびにその塩例えばアルカリ金属塩、アンモ
ニウム塩又は有機アンモニウム塩の形で使用でき
る。シアン化アルカリとしては、例えばシアン化
カリウム又はシアン化ナトリウムが用いられる。 A compound of formula may be, for example, 2-mercapto-
It is obtained by halogenating εCAMP (see JP-A-53-12891), and for example, 2-iodo-εCAMP, 2-chloro-εCAMP or preferably 2-bromo-εCAMP is used. The compounds of these formulas can be used in the form of the free acid in the cyclic phosphoric acid moiety as well as in the form of its salts, such as alkali metal salts, ammonium salts or organic ammonium salts. As the alkali cyanide, for example, potassium cyanide or sodium cyanide is used.
シアン化反応は、例えば次のように行うことが
できる。式の化合物を好ましくは極性有機溶
媒、例えばN,N′−ジメチルホルムアミド等に
溶解もしくは懸濁させ、これにシアン化アルカリ
を添加し、室温ないし60℃の温度において数時間
ないし数日間反応させる。 The cyanation reaction can be carried out, for example, as follows. A compound of the formula is preferably dissolved or suspended in a polar organic solvent, such as N,N'-dimethylformamide, and an alkali cyanide is added thereto, followed by reaction at a temperature of room temperature to 60°C for several hours to several days.
Rがカルバモイル基又はカルボキシル基である
式の化合物(2−カルバモイル−εCAMP又は
2−カルボキシ−εCAMP)は、2−シアノ−
εCAMPをアルカリ水解することにより、アルカ
リ水解条件、例えばアルカリ性の強さ(PH)、反
応時間などに応じて得られる。すなわちシアノ基
がまずカルバモイル基(カルボンアミド基)に水
解され、さらに水解が進んでカルボキシル基とな
る。 A compound of the formula in which R is a carbamoyl group or a carboxyl group (2-carbamoyl-εCAMP or 2-carboxy-εCAMP) is a 2-cyano-
It can be obtained by alkaline hydrolysis of εCAMP depending on the alkaline hydrolysis conditions, such as alkaline strength (PH), reaction time, etc. That is, a cyano group is first hydrolyzed into a carbamoyl group (carbonamide group), and then further hydrolyzed to become a carboxyl group.
アルカリ水解は、一般に水、アルコール等の親
水性溶媒の存在下に、塩基性物質例えば水酸化ナ
トリウム、水酸化カリウム、アンモニア、有機ア
ミン等を用いて行われる。 Alkaline hydrolysis is generally carried out using a basic substance such as sodium hydroxide, potassium hydroxide, ammonia, or an organic amine in the presence of a hydrophilic solvent such as water or alcohol.
2−シアノ−εCAMPのアルカリ水解を、塩基
性物質の添加により例えばPH10〜13の範囲で一般
に0〜40℃の温度において数分ないし数時間行う
と、2−カルバモイル−εCAMPが得られる。 2-Carbamoyl-εCAMP is obtained by alkaline hydrolysis of 2-cyano-εCAMP by addition of a basic substance, for example, at a pH of 10 to 13 and generally at a temperature of 0 to 40°C for several minutes to several hours.
前記の2−カルバモイル−εCAMPを含む反応
混合物を0〜40℃の温度でさらに長時間水解を続
けるか、あるいは反応混合物に追加量の塩基性物
質を添加してPH12〜13.5となし、一般に0〜40℃
の温度において数分ないし数時間水解を行うと、
2−カルボキシ−εCAMPが得られる。また2−
シアノ−εCAMP、2−カルバモイル−εCAMP
又は両者の混合物を親水性溶媒に溶解もしくは懸
濁させ、これに塩基性物質を添加して液性をPH12
〜13.5の範囲に調整し、一般に0〜40℃の温度に
おいて数分ないし数時間水解すると、2−カルボ
キシ−εCAMPが得られる。 The reaction mixture containing 2-carbamoyl-εCAMP is continued to be hydrolyzed for a longer period of time at a temperature of 0 to 40°C, or an additional amount of a basic substance is added to the reaction mixture to give a pH of 12 to 13.5, generally 0 to 40°C. 40℃
When hydrolysis is carried out for several minutes to several hours at a temperature of
2-carboxy-εCAMP is obtained. Also 2-
Cyano-εCAMP, 2-carbamoyl-εCAMP
Alternatively, dissolve or suspend a mixture of both in a hydrophilic solvent, and add a basic substance to this to adjust the liquid pH to 12.
13.5 and hydrolysis at a temperature of generally 0 to 40° C. for several minutes to several hours, 2-carboxy-εCAMP is obtained.
目的物質の単離精製は常法により行われ、操
作条件により環状リン酸部及び/又はカルボキシ
ル基における遊離酸又はその塩の形の式の化合
物が得られる。例えば反応混合物を濃縮し、無機
酸例えば塩酸等又は有機酸たとえば酢酸等を用い
てPH価を4以下に調整したのち、しばらくの間放
置すると、遊離酸の形の目的物質が析出する。
反応混合物中に塩類、色素等の分離し難い副生物
が存在する場合には、例えば活性炭、イオン交換
樹脂例えば強酸性陽イオン交換樹脂又は弱塩基性
陰イオン交換樹脂等、アルミナ、シリカゲル等を
用いるカラムクロマトグラフイー又はアルコー
ル、アセトン、ジオキサン等を用いる有機溶媒沈
殿法等を単独で又は組合わせて行うことができ
る。 Isolation and purification of the target substance is carried out by conventional methods, and depending on the operating conditions, a compound of the formula in the form of a free acid or a salt thereof in the cyclic phosphoric acid moiety and/or carboxyl group can be obtained. For example, after concentrating the reaction mixture and adjusting the PH value to 4 or less using an inorganic acid such as hydrochloric acid or an organic acid such as acetic acid, and leaving it for a while, the desired substance in the form of a free acid will precipitate.
When there are by-products such as salts and pigments in the reaction mixture that are difficult to separate, use activated carbon, ion exchange resins such as strongly acidic cation exchange resins or weakly basic anion exchange resins, alumina, silica gel, etc. Column chromatography or organic solvent precipitation using alcohol, acetone, dioxane, etc. can be performed alone or in combination.
遊離酸の形の式の化合物に常法により塩基性
物質、例えば水酸化ナトリウム、水酸化カリウ
ム、アンモニア、アミン好ましくは三級アミン例
えばトリエチルアミン、トリブチルアミン等を作
用させると、対応する塩に導くことができる。 When a compound of the formula in the form of a free acid is reacted with a basic substance such as sodium hydroxide, potassium hydroxide, ammonia, an amine, preferably a tertiary amine such as triethylamine, tributylamine, etc. in a conventional manner, it leads to the corresponding salt. Can be done.
式の新規化合物は、2−カルバモイル−及び
特に2−カルボキシ−アデノシン−3′,5′−環状
リン酸(以下アデノシン−3′,5′−環状リン酸を
CAMPと略称する)の合成用中間体としても重
要である。例えば2−カルバモイル−εCAMP又
は2−カルボキシ−εCAMPを脱エテノ化する
と、2−カルバモイル−CAMP又は2−カルボ
キシ−CAMPが得られる。2−カルボキシ−
CAMPは、2−カルバモイル−εCAMP又は2−
シアノ−εCAMPをそれぞれ脱エテノ化したのち
アルカリ水解することによつても得られる。 The novel compounds of the formula
It is also important as an intermediate for the synthesis of CAMP. For example, deethenoization of 2-carbamoyl-εCAMP or 2-carboxy-εCAMP yields 2-carbamoyl-CAMP or 2-carboxy-CAMP. 2-carboxy-
CAMP is 2-carbamoyl-εCAMP or 2-carbamoyl-εCAMP
It can also be obtained by deethenoizing cyano-εCAMP and then subjecting it to alkaline hydrolysis.
実施例 1
2−ブロモ−εCAMP2.0gをジメチルホルムア
ミド500mlに懸濁し、これにシアン化カリウム1.0
gを添加し、充分混和したのち室温で16時間撹拌
下に反応させる。Example 1 2.0 g of 2-bromo-εCAMP was suspended in 500 ml of dimethylformamide, and 1.0 g of potassium cyanide was added to it.
After stirring thoroughly, the mixture was reacted at room temperature for 16 hours with stirring.
反応終了後、反応混合物にダウエツクス50−
X8(H+型)を添加して中和したのち過し、
液を蒸発乾固する。残査を少量の水に溶解し、こ
れをダウエツクス50−X8(H+型、100〜200メツ
シユ)の充填されたカラム(1.4φ×30cm)を通過
させ、水で溶出し、次いで目的化合物を含有する
溶出区分を濃縮し、5℃に放置すると、2−シア
ノ−εCAMPが結晶化し、これを別して乾燥す
ると、2−シアノ−εCAMPの結晶1.11gが得ら
れる。 After the reaction is complete, add Dowex 50-
After neutralizing by adding X8 (H + type),
Evaporate the liquid to dryness. The residue was dissolved in a small amount of water, passed through a column (1.4φ x 30cm) packed with Dowex 50-X8 (H + type, 100-200 mesh), eluted with water, and then the target compound was extracted. When the eluted fraction containing the fraction is concentrated and left at 5°C, 2-cyano-εCAMP crystallizes, and when this is separated and dried, 1.11 g of crystals of 2-cyano-εCAMP are obtained.
融点:191〜193℃(分解)
元素分析:C13H11N6O6P・0.5H2Oとして
C H N
理論値(%) 40.37 3.03 21.66
実測値(%) 40.31 3.10 21.71
紫外部吸収スペクトル:
λ0.1N-HCl nax242.5、249.0(肩)、273.0(肩)、281.
0、
294.0、333.5nm
実施例 2
2−シアノ−εCAMP1.0gを0.7N水酸化ナト
リウム水溶液10mlに溶解し(PH12.9)、室温で5
分間撹拌下に反応させる。反応混合物のPHを濃塩
酸を用いて1.0に調整し、析出した結晶を取し、
少量の水で水洗後乾燥すると、2−カルバモイル
−εCAMPの結晶793mgが得られる。Melting point: 191-193℃ (decomposition) Elemental analysis: C 13 H 11 N 6 O 6 P・0.5H 2 O C H N Theoretical value (%) 40.37 3.03 21.66 Actual value (%) 40.31 3.10 21.71 Ultraviolet absorption spectrum : λ 0.1N-HCl nax 242.5, 249.0 (shoulder), 273.0 (shoulder), 281.
0,
294.0, 333.5nm Example 2 1.0g of 2-cyano-εCAMP was dissolved in 10ml of 0.7N aqueous sodium hydroxide solution (PH12.9), and the
Allow to react under stirring for a minute. Adjust the pH of the reaction mixture to 1.0 using concentrated hydrochloric acid, collect the precipitated crystals,
After washing with a small amount of water and drying, 793 mg of 2-carbamoyl-εCAMP crystals are obtained.
融点:196〜199℃(分解)
元素分析:C13H13N6O7P・H2Oとして
C H N
理論値(%) 37.65 3.34 20.12
実測値(%) 37.68 3.62 20.29
紫外部吸収スペクトル:
λ0.1N-HCl nax239.5、278.0、308.5nm
実施例 3
2−カルバモイル−εCAMP1.0gを1.3N−水
酸化ナトリウム水溶液10mlに溶解し(PH13.2)、
室温で20分間撹拌下に反応させたのち、反応混合
物のPHを濃塩酸を用いて1.0に調整する。析出し
た結晶を別したのち乾燥すると、2−カルボキ
シ−εCAMPの結晶843mgが得られる。Melting point: 196-199℃ (decomposition) Elemental analysis: C 13 H 13 N 6 O 7 P・H 2 O C H N Theoretical value (%) 37.65 3.34 20.12 Actual value (%) 37.68 3.62 20.29 Ultraviolet absorption spectrum: λ 0.1N-HCl nax 239.5, 278.0, 308.5nm Example 3 1.0g of 2-carbamoyl-εCAMP was dissolved in 10ml of 1.3N-sodium hydroxide aqueous solution (PH13.2),
After reacting at room temperature for 20 minutes with stirring, the pH of the reaction mixture is adjusted to 1.0 using concentrated hydrochloric acid. The precipitated crystals were separated and dried to obtain 843 mg of 2-carboxy-εCAMP crystals.
融点:220〜202℃(分解)
元素分析:C13H12N5O8P・1.5H2Oとして
C H N
理論値(%) 36.57 3.47 16.61
実測値(%) 36.79 3.54 16.51
紫外部吸収スペクトル:
λ0.1N-HCl nax237.5、276.5、284.0(肩)、306.0(肩
)n
m
λ0.1N-NaOH nax237.5、270.0(肩)、322.0nm
前記と同様に操作し、ただし2−カルバモイル
−εCAMPの代わりに2−シアノ−εCAMPを用
いると、2−カルボキシ−εCAMPが得られる。Melting point: 220-202℃ (decomposed) Elemental analysis: C 13 H 12 N 5 O 8 P・1.5H 2 O C H N Theoretical value (%) 36.57 3.47 16.61 Actual value (%) 36.79 3.54 16.51 Ultraviolet absorption spectrum : λ 0.1N-HCl nax 237.5, 276.5, 284.0 (shoulder), 306.0 (shoulder) n
m λ 0.1N-NaOH nax 237.5, 270.0 (shoulder), 322.0 nm By operating in the same manner as above but using 2-cyano-εCAMP instead of 2-carbamoyl-εCAMP, 2-carboxy-εCAMP is obtained.
Claims (1)
キシル基を意味する)で表わされる2−置換−
1,N6−エテノ−アデノシン−3′,5′−環状リン
酸。 2 一般式 (式中Xはハロゲン原子を意味する)で表わされ
る2−ハロゲノ−1,N6−エテノ−アデノシン
−3′,5′−環状リン酸にシアン化アルカリを作用
させることを特徴とする、一般式 (式中Rはシアノ基、カルバモイル基又はカルボ
キシル基を意味する)で表わされる2−置換−
1,N6−エテノ−アデノシン−3′,5′−環状リン
酸の製法。 3 シアン化アルカリを作用させたのちアルカリ
水解して、Xをカルバモイル基又はカルボキシル
基に交換する特許請求の範囲第2項に記載の方
法。[Claims] 1. General formula (wherein R means a cyano group, carbamoyl group or carboxyl group) 2-substituted-
1,N 6 -etheno-adenosine-3',5'-cyclic phosphoric acid. 2 General formula (In the formula, X means a halogen atom) 2-halogeno-1,N 6 -etheno-adenosine-3',5'-cyclic phosphoric acid is reacted with an alkali cyanide. formula (wherein R means a cyano group, carbamoyl group or carboxyl group) 2-substituted-
1. Method for producing N 6 -etheno-adenosine-3',5'-cyclic phosphoric acid. 3. The method according to claim 2, wherein X is exchanged with a carbamoyl group or a carboxyl group by reacting with an alkali cyanide and then performing alkali hydrolysis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5800679A JPS55151599A (en) | 1979-05-14 | 1979-05-14 | Novel 2-substituted-1,n6-etheno adenosine-3',5'-cyclic phosphoric acid and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5800679A JPS55151599A (en) | 1979-05-14 | 1979-05-14 | Novel 2-substituted-1,n6-etheno adenosine-3',5'-cyclic phosphoric acid and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS55151599A JPS55151599A (en) | 1980-11-26 |
JPS638960B2 true JPS638960B2 (en) | 1988-02-25 |
Family
ID=13071880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5800679A Granted JPS55151599A (en) | 1979-05-14 | 1979-05-14 | Novel 2-substituted-1,n6-etheno adenosine-3',5'-cyclic phosphoric acid and its preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS55151599A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020189389A1 (en) | 2019-03-19 | 2020-09-24 | 株式会社ジェイエスピー | Polyolefin-based resin foam particles, polyolefin-based resin foam particle molded body, and production method for polyolefin-based resin foam particles |
-
1979
- 1979-05-14 JP JP5800679A patent/JPS55151599A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020189389A1 (en) | 2019-03-19 | 2020-09-24 | 株式会社ジェイエスピー | Polyolefin-based resin foam particles, polyolefin-based resin foam particle molded body, and production method for polyolefin-based resin foam particles |
Also Published As
Publication number | Publication date |
---|---|
JPS55151599A (en) | 1980-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS60178887A (en) | Preparation of 5,6,7,8-tetrahydro-l-biopterin | |
NO146541B (en) | PROCEDURE FOR PREPARING SOFT ETHYLENIC POLYMER RESIN FOAM | |
JPS638960B2 (en) | ||
US3079379A (en) | Method for the preparation of adenosine 5'-triphosphate | |
JPS635400B2 (en) | ||
EP0061001A1 (en) | Antiallergic agent comprising derivatives of adenosine | |
JPH058200B2 (en) | ||
JPS6043079B2 (en) | Method for producing choline cytidine diphosphate | |
JPH0531559B2 (en) | ||
JP2640980B2 (en) | N @ 6, N @ 6--disubstituted-adenosine-3 ', 5'-cyclic phosphoric acid and process for producing the same | |
JPS591719B2 (en) | Method for producing thymine derivatives | |
JPS633877B2 (en) | ||
JPS59116298A (en) | Preparation of 6,8-substituted-adenosine-3',5'-cyclic phosphoric acid and its salt | |
JPS6043078B2 (en) | Production method of choline cytidine diphosphate | |
HU203553B (en) | New process for producing oxetanocin g | |
JPS629598B2 (en) | ||
JPS601199A (en) | Preparation of cytidine-5'-diphosphate choline | |
JPH0532394B2 (en) | ||
JPH0158188B2 (en) | ||
JPS5930720B2 (en) | Method for producing 5-bromouracil nucleoside | |
JPH0335913B2 (en) | ||
SU558533A1 (en) | Method of preparing reumycin | |
JPH02233692A (en) | Novel n6,2'-o-disubstituted-adenosine-3',5'-cyclic phosphate and production thereof | |
SU1270153A1 (en) | 5'-0-tritolmethyl derivatives of 2'-desoxynucleosides as starting substances in synthesis of oligonucleotides | |
JPH0764868B2 (en) | Novel N 6 above, N 6 above, 2'-0-tri-substituted-adenosine-3 ', 5'-cyclic phosphate and process for producing the same |